SCHEMBL1995704

SCHEMBL1995704

O=C1NC(=O)C(c2c[nH]c3ccsc23)=C1c1nn(C2CCN(CC(F)(F)F)CC2)c2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAMK2D Q13557 11/20 0.41
PRKCB P05771 10/20 0.39
PRKCA P17252 10/20 0.39
PRKCH P24723 10/20 0.39
PRKCE Q02156 10/20 0.39
PRKCD Q05655 10/20 0.39
PRKCG P05129 7/20 0.39
CAMK2A Q9UQM7 7/20 0.39
CAMK2B Q13554 6/20 0.39
CAMK2G Q13555 6/20 0.39
PRKCZ Q05513 5/20 0.39
SRC P12931 3/20 0.39
JAK3 P52333 4/20 0.36
GSK3B P49841 3/20 0.36
JAK1 P23458 2/20 0.36
JAK2 O60674 1/20 0.36
TYK2 P29597 1/20 0.36
PRKCQ Q04759 5/20 0.35
PIM1 P11309 5/20 0.35
GSK3A P49840 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1994738 0.91 PRKCA (0.40) CAMK2DPRKCBPRKCAPRKCHPRKCE
SCHEMBL1990865 0.90 CAMK2D (0.45) CAMK2DPRKCBPRKCAPRKCHPRKCE
SCHEMBL1998512 0.89 PRKCA (0.39) CAMK2DPRKCBPRKCAPRKCHPRKCE
SCHEMBL1997240 0.89 CAMK2D (0.41) CAMK2DPRKCBPRKCAPRKCHPRKCE
SCHEMBL1996716 0.88 CAMK2D (0.39) CAMK2DPRKCBPRKCAPRKCHPRKCE
SCHEMBL1991560 0.88 CAMK2D (0.45) CAMK2DPRKCBPRKCAPRKCHPRKCE
SCHEMBL1994230 0.86 PRKCB (0.43) CAMK2DPRKCBPRKCAPRKCHPRKCE
SCHEMBL1992944 0.86 PRKACA (0.44) CAMK2DPRKCBPRKCAPRKCHPRKCE
SCHEMBL1996178 0.85 CAMK2D (0.56) CAMK2DPRKCBPRKCAPRKCHPRKCE
SCHEMBL1991372 0.80 PRKACA (0.53) CAMK2DPRKCBPRKCAPRKCHPRKCE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011079105-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-30 WO disclosed
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS TPMT, TSLP, THPO CAMK2D 2963/4885PRKCB 3335/4885PRKCA 3438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.